
Company valuation, historical trends, and peer comparisons.
According to Turnstone Biologics Corp.’s latest financial reports and current stock price. The company's current Enterprise Value is -19522051.00. This represents a change of 71.55% compared to the average of -11379548.12 of the last 4 quarters.
The mean historical Enterprise Value of Turnstone Biologics Corp. over the last ten years is 89.61M. The current -19522051.00 Enterprise Value has changed -121.79% with respect to the historical average. Over the past ten years (40 quarters), TSBX's Enterprise Value was at its highest in in the June 2023 quarter at 226.75M. The Enterprise Value was at its lowest in in the December 2024 quarter at -16278611.72.
Average
89.61M
Median
80.11M
Minimum
-16289875.94
Maximum
214.51M
Discovering the peaks and valleys of Turnstone Biologics Corp. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 73.87%
Maximum Annual Enterprise Value = 214.51M
Minimum Annual Increase = -144.22%
Minimum Annual Enterprise Value = -16289875.94
| Year | Enterprise Value | Change |
|---|---|---|
| 2024 | -16289875.94 | -144.22% |
| 2023 | 36.84M | -82.83% |
| 2022 | 214.51M | 73.87% |
The current Enterprise Value of Turnstone Biologics Corp. (TSBX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
78.35M
5-year avg
89.61M
10-year avg
89.61M
Turnstone Biologics Corp.’s Enterprise Value is less than Tvardi Therapeutics, Inc. (-4463344.00), less than Biora Therapeutics, Inc. (32.22M), less than Omega Therapeutics, Inc. (67.88M), less than Channel Therapeutics Corporation (30.58M), less than IMV Inc. (17.06M), less than COSCIENS Biopharma Inc. (2.75M), less than Apexigen, Inc. (-5121682.00), less than TNF Pharmaceuticals, Inc. (3.59M), less than Kineta, Inc. (7.04M), less than CervoMed Inc. (2.79M),
| Company | Enterprise Value | Market cap |
|---|---|---|
| -4463344.00 | $11.16M | |
| 32.22M | $994.99K | |
| 67.88M | $7.90M | |
| 30.58M | $8.90M | |
| 17.06M | $23.42K | |
| 2.75M | $8.57M | |
| -5121682.00 | $9.57M | |
| 3.59M | $9.18M | |
| 7.04M | $7.05M | |
| 2.79M | $25.25M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Turnstone Biologics Corp. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Turnstone Biologics Corp. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Turnstone Biologics Corp.'s Enterprise Value?
What is the highest Enterprise Value for Turnstone Biologics Corp. (TSBX)?
What is the 3-year average Enterprise Value for Turnstone Biologics Corp. (TSBX)?
What is the 5-year average Enterprise Value for Turnstone Biologics Corp. (TSBX)?
How does the current Enterprise Value for Turnstone Biologics Corp. (TSBX) compare to its historical average?